Zydus to launch Semaglutide Injection in India, featuring a unique reusable pen for improved diabetes and obesity management.

Zydus has received regulatory approval from the Drug Controller General of India (DCGI) to market and manufacture semaglutide ...

DCGI had earlier provided its approval for manufacturing and marketing Semaglutide injection for the treatment of Type 2 ...

Zydus plans to launch its diabetes and obesity injection using a reusable adjustable pen device after patent expiry, as more Indian drugmakers enter the market.

One of the standout features of Zydus' semaglutide offering is its unique, indigenously developed drug delivery system ...

Feb 25 - Zydus Lifesciences will launch generic versions of semaglutide injections for ‌obesity and diabetes in India after ‌patent expiry of the Ozempic active ingredient in ​late March, it said on ...

A daily pill version of Wegovy worked just as well as the weekly shot in clinical trials. If approved by the FDA, the pills could be a nice option for people with obesity and needle phobias. The pill ...

Eli Lilly has rolled out a multi-dose KwikPen version of tirzepatide, marketed as Zepbound, for chronic weight management—signaling a packaging update for one of the obesity market’s fastest-expanding ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...